Readers of MassTortDefense know how the conduct and results of clinical trials can reach out and affect later product liability litigation: plaintiffs
Continue Reading PhRMA Issues New Principles on Clinical Trials
ghostwriting
Senator Writes Letter To NIH About “Ghostwriting”
By Sean Wajert on
Posted in Articles, Drug and Device
Plaintiffs in pharmaceutical and other biomedical litigation have frequently resorted to allegations of “ghostwriting” to attack various a…
Continue Reading Senator Writes Letter To NIH About “Ghostwriting”